Security key
75340L104
CUSIP: 75340L104
Security key
75340L104
Report period
Q4 2025
Institutions
42
Top holders
10
Broader feeds
Reporting periods
Recent filing periods:
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Robert G. Spignesi Jr. |
13D/G
SPIGNESI ROBERT G JR
|
6.3%
|
$9,133,033
2,647,256 shares
|
$0 | 28 Mar 2024 |
| Endeavour Medtech Growth II LP |
13D/G
|
5.7%
|
$6,545,587
2,257,099 shares
|
$0 | 31 Dec 2025 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
21%
|
$28,171,430
8,434,560 shares
|
— | 30 Sep 2025 |
| ABG-WTT Global Life Science Capital Partners GP Ltd |
13F
Company
|
4.5%
|
$6,173,309
1,848,296 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
2.4%
|
$3,223,160
965,018 shares
|
— | 30 Sep 2025 |
| Parkman Healthcare Partners LLC |
13F
Company
|
2.2%
|
$3,050,900
913,443 shares
|
— | 30 Sep 2025 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Investor-level positions for this CUSIP, loaded as an interactive table.
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).